Magstim

Executive Summary

Magstim, headquartered in Carmarthenshire, UK, is a pioneering neurotechnology company with over four decades of experience in Transcranial Magnetic Stimulation (TMS), Electroencephalography (EEG), Transcranial Direct Current Stimulation (tDCS), and multi-modality integrated solutions. The company serves as a comprehensive partner for neuroscience research and clinical applications, offering a range of devices that combine stimulation and recording modalities. Magstim's long-standing presence in the industry underscores its commitment to innovation and quality, though it remains a private entity with limited publicly available financial or pipeline details. Given its established reputation, Magstim is well-positioned to benefit from the growing adoption of non-invasive brain stimulation in treating neurological and psychiatric disorders, as well as in research settings. However, the lack of disclosed funding or commercial-stage products suggests a need for clearer market traction or upcoming milestones to drive conviction.

Upcoming Catalysts (preview)

• Q3 2026Launch of Next-Generation Integrated TMS-EEG System70% success
• TBDFDA Clearance for Expanded Indication in Major Depressive Disorder50% success
• Q4 2026Strategic Partnership with Major Neuroscience Research Institution60% success